NiSource, Inc. : The underlying trend is to the upside
| Entry price | Target | Stop-loss | Potential |
|---|
|
US$43.79 |
US$46.85 |
US$42 |
+6.99% |
|---|
The current trading zone is interesting to the point that investors should pay attention to the stock and anticipate a return of the underlying upward trend.
Summary● According to MSCI, the company's ESG score for its industry is good.
● The earnings growth currently anticipated by analysts for the coming years is particularly strong.
● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
● One of the major weak points of the company is its financial situation.
● With an enterprise value anticipated at 5.99 times the sales for the current fiscal year, the company turns out to be overvalued.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
● Over the past twelve months, analysts' opinions have been revised negatively.
● The group usually releases earnings worse than estimated.
© MarketScreener.com -
2025
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener UK. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
